IRIS - Res&Arch Institutional Research Information System - Research & Archive

ANGELI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.397
EU - Europa 1.098
AS - Asia 484
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.389
IE - Irlanda 254
UA - Ucraina 212
SG - Singapore 210
IT - Italia 184
SE - Svezia 181
VN - Vietnam 107
HK - Hong Kong 92
FI - Finlandia 70
DE - Germania 64
RU - Federazione Russa 60
CN - Cina 50
GB - Regno Unito 21
FR - Francia 13
AT - Austria 11
CH - Svizzera 10
TR - Turchia 10
BE - Belgio 6
CA - Canada 6
KR - Corea 5
UZ - Uzbekistan 5
NL - Olanda 4
GR - Grecia 3
NZ - Nuova Zelanda 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
MX - Messico 2
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
EU - Europa 1
LB - Libano 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
Totale 2.985
Salva come PNG Salva come JPEG
Città #
Chandler 295
Dublin 254
Singapore 178
San Mateo 140
Jacksonville 136
Dong Ket 107
Hong Kong 92
Altamura 91
Boardman 90
Santa Clara 73
Medford 69
Princeton 69
Lawrence 67
Wilmington 57
Perugia 48
Beijing 35
Ann Arbor 24
Andover 21
Saint Petersburg 16
Des Moines 15
Norwalk 11
Helsinki 10
Izmir 10
Falls Church 9
San Paolo di Civitate 9
Redwood City 8
Ashburn 7
Brussels 6
New York 6
Woodbridge 6
Seoul 5
Shanghai 5
Amelia 4
Seattle 4
Toronto 4
Vienna 4
Cagliari 3
London 3
Los Angeles 3
Munich 3
Redmond 3
Rome 3
San Diego 3
Amsterdam 2
Auckland 2
Den Haag 2
L’Aquila 2
Moscow 2
Tappahannock 2
Auburn Hills 1
Belgrade 1
Boston 1
Brisbane 1
Cambridge 1
Campello Sul Clitunno 1
Chengdu 1
Clifton 1
Council Bluffs 1
Dallas 1
Deva 1
Dhaka 1
East Amherst 1
Hamburg 1
Hengyang 1
Houston 1
Jianning 1
Kiev 1
Lachine 1
Lausanne 1
Linköping 1
Magliano Sabina 1
Miami 1
Nuremberg 1
Ottawa 1
Pakistan 1
Piracicaba 1
Pittsburgh 1
Prato 1
Rheinfelden 1
San Costanzo 1
San Jose 1
Tianjin 1
Whangarei 1
Totale 2.052
Salva come PNG Salva come JPEG
Nome #
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 74
Improved cardiovascular risk stratification by a simple ECG index in hypertension 72
New-onset diabetes, antihypertensive treatment, and outcome 71
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 70
Above which blood pressure level does the risk of atrial fibrillation increase? 69
Adverse prognostic significance of new diabetes in treated hypertensive subjects 68
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 67
Aliskiren versus ramipril in hypertension. 66
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? 60
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 60
Angiotensin receptor blockers in hypertension. New insights from Japan. 60
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 59
Angiotensin-converting enzyme inhibitors 58
Microalbuminuria and hypertension. 57
Betabloccanti e ipertensione arteriosa. Evidence-based medicine o eccessivo accanimento? 56
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 55
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 54
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity 53
Optimal therapy in hypertensive subjects with diabetes mellitus 53
Modernization and hypertension: is the link changing? 53
Blood pressure lowering in diabetic patients. 52
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 51
Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. 51
New-onset diabetes in treated hypertensive patients 51
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 50
Prehypertension and Cardiometabolic Syndrome 50
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 49
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 49
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents. 49
Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention 49
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 48
Quali novità nella gestione dell’ipertensione arteriosa dopo le recenti linee guida europee e nordamericane? 48
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. 47
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 47
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. 47
Comparative assessment of angiotensin receptor blockers in different clinical settings. 46
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 45
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 44
Telmisartan for the reduction of cardiovascular morbidity and mortality. 44
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 44
Modern treatment of patients at risk: stilla HOPE for ACE inhibitors? 43
Good news for beta-blockers in perioperative medicine. 38
Statins in acute coronary syndrome: very early initiation and benefits. 36
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. 36
Diuretic treatment of hypertension 36
Hypertension around the world: new insights from developing countries. 35
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 35
Perioperative beta blockade: the debate continues. 34
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension 33
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. 33
White-coat hypertension in adults. 33
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 32
Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography 32
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure? 31
Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease 31
II monitoraggio ambulatoriale della pressione arteriosa nella pratica clinica 30
Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension. 30
Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? 29
Protein intake in type 1 diabetes: putting controversies into perspectives. 29
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 27
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension 26
Prognostic value of lipoprotein fractions in essential hypertension. 26
Multivariable analysis in cerebrovascular research: practical notes for the clinician. 25
Neutrophil count and ambulatory pulse pressure as predictors of cardiovascularadverse events in postmenopausal women with hypertension 25
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 24
Fixed-dose combination therapy in hypertension: cons. 22
Mecanismos de la hipertrofia ventricular izquierda en la hipertensión: Más que solo la presión arterial 22
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. 21
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? 19
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 13
Totale 3.082
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020131 0 0 0 0 0 0 33 4 45 30 11 8
2020/2021564 1 31 17 32 172 35 39 1 54 21 46 115
2021/2022472 9 86 18 35 11 5 1 167 4 3 61 72
2022/2023969 71 218 8 65 89 87 3 62 310 4 37 15
2023/2024325 24 44 17 5 5 1 58 2 38 10 46 75
2024/2025299 4 76 29 51 105 34 0 0 0 0 0 0
Totale 3.082